US Non-alcoholic Steatohepatitis Therapeutic & Diagnostic Market: Growth Trends, and Opportunities
The United States holds a leading position in the Non-alcoholic Steatohepatitis Therapeutic & Diagnostic Market, driven by the high prevalence of obesity, type 2 diabetes, and metabolic syndrome, which are major risk factors for liver disease. The country benefits from a strong healthcare infrastructure, significant investments in liver disease research, and the presence of leading … Read more